The business has just received the accolade of Start-Up of the Year at the 17th awards hosted by BioNow, the northern England bio-medical and life sciences membership organisation.

The company’s early success is based on delivering expertise in safety toxicology and ion channel electrophysiology to a changing pharmaceutical sector, in which more companies are outsourcing their essential drug safety testing and analysis.

Founded in 2015 by Professor Ruth Roberts, Dr Richard Knight and Dr Michael Morton following many years working at Astra Zeneca, ApconiX has already recruited a group of leading scientists with wide-ranging skills in preclinical drug safety.

Read more here: Alderley Park’s ApconiX Achieves Five-Fold Turnover Boost Via Pharma Sector Demand for Drug Safety Expertise